Saving a major pharma company with multiple business lines 50% in media intelligence costs

How Fullintel’s centralized media monitoring and reporting provides economies of scale, improved data quality, and an accurate view of each business unit’s performance

The Client

A major international pharmaceutical company, founded several decades ago, that performs R&D activities and product development based on a range of medical disorders including neurological, hematological, oncological, gastrointestinal, and other issues. This breadth of activities and corresponding therapeutic products means the company has several distinct therapeutic lines, each with their own unique set of products, branding, and PR/communications requirements.